Hematopoietic cell transplantation can be safely performed after COVID-19.
Resource Type
Editorial & Opinion
Authors
Marinos A; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA. alejandro.marinosvelarde@utsouthwestern.edu.; Ramdial J; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khawaja F; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Saliba RM; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shigle TL; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Alousi AM; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rondon G; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen J; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ledesma C; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Champlin RE; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daher M; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen G; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marin D; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rezvani K; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shpall EJ; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chemaly RF; Affiliation University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Source
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE